Frontlight ResearchEarly access
Hodgkin lymphoma trials in Czechia
7 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Taking peopleA Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity of Glofitamab in Monotherapy and in Combination with Chemoimmunotherapy in Pediatric and Young Adult Participants with Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma
- Where
- Prague
- Age
- Up to 17 years
- People
- 37 worldwide
- Run by
- F. Hoffmann-La Roche AG
See details and how to join2023-504264-41-00 - No phaseTaking peopleEarly Detection and Screening of Hematological Malignancies - SANGUINE
- Where
- Olomouc
- Age
- 18 years and over
- People
- 3,000 worldwide
- Run by
- JaxBio Ltd
See details and how to joinNCT05735704 - Phase 3Not yet taking people in CzechiaA Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Secondary Antibody Deficiency Associated With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma
- Where
- Ostrava, Plzen 23, Praha 10
- Age
- 18 years and over
- People
- 49 worldwide
- Run by
- Grifols Biologicals, LLC
See details and how to joinNCT07582432 · EU 2026-526803-31-00 - Phase 1Taking peopleA Phase 1b Open-Label Study to Evaluate the Safety and Anti-cancer Activity of Loncastuximab Tesirine in Combination with Other Anti-cancer Agents in Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (LOTIS-7)
- Where
- Ostrava, Prague, Prague 10
- Age
- 18 years and over
- People
- 121 worldwide
- Run by
- ADC Therapeutics SA
See details and how to joinNCT04970901 · EU 2024-512089-32-00 - Phase 3CompletedA trial to learn how effective and safe odronextamab is compared to standard of care for adult participants with previously treated aggressive B-cell Non-Hodgkin Lymphoma.
- Where
- Prague 10
- Age
- 18 years and over
- People
- 132 worldwide
- Run by
- Regeneron Pharmaceuticals Inc.
See details and how to joinNCT06230224 · EU 2022-502783-21-00 - Phase 1Taking peopleCART19 Cells Effects in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Non-Hodgkin's Lymphoma
- Where
- Prague
- Age
- 18 years to 80 years
- People
- 10
- Run by
- Institute of Hematology and Blood Transfusion, Czech Republic
See details and how to joinNCT05054257 · EU 2024-510815-30-00 - No phaseTaking peoplePrognostic Significance of ctDNA in HL
- Where
- Hradec Králové, Olomouc, Prague
- Age
- 18 years and over
- People
- 500
- Run by
- Interni hematologicka klinika FNKV
See details and how to joinNCT06263530